Bioventus Inc.
NASDAQ:BVS
11.59 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 36.964 | 31.814 | 43.933 | 86.839 | 64.52 | 42.774 | 4.95 | 15.774 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 36.964 | 31.814 | 43.933 | 86.839 | 64.52 | 42.774 | 4.95 | 15.774 |
| Net Receivables
| 123.046 | 136.645 | 124.963 | 88.283 | 85.128 | 72.569 | 54.511 | 47.075 |
| Inventory
| 91.333 | 85.408 | 61.688 | 29.12 | 27.326 | 27.396 | 35.178 | 26.674 |
| Other Current Assets
| 16.656 | 18.685 | 27.239 | 7.552 | 6.059 | 5.615 | 4.788 | 5.708 |
| Total Current Assets
| 267.999 | 272.575 | 263.103 | 211.794 | 183.033 | 148.354 | 99.427 | 95.231 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 49.958 | 44.955 | 40.171 | 21.84 | 19.756 | 4.759 | 9.602 | 10.428 |
| Goodwill
| 7.462 | 13.759 | 147.623 | 49.8 | 49.8 | 49.8 | 58.694 | 49.953 |
| Intangible Assets
| 482.35 | 1,038.724 | 695.193 | 191.65 | 216.51 | 237.029 | 319.152 | 274.332 |
| Goodwill and Intangible Assets
| 489.812 | 1,052.483 | 842.816 | 241.45 | 266.31 | 286.829 | 377.846 | 324.285 |
| Long Term Investments
| -1.213 | 2.636 | 29.291 | 19.382 | 3.308 | 2.781 | 0 | 0 |
| Tax Assets
| 1.213 | 154.001 | 0.481 | -19.382 | -3.308 | -2.781 | 0.084 | 0.179 |
| Other Non-Current Assets
| 3.141 | -154.001 | 50 | 19.382 | 3.308 | 2.781 | 0.393 | 0.298 |
| Total Non-Current Assets
| 542.911 | 1,100.074 | 962.759 | 282.672 | 289.374 | 294.369 | 387.925 | 335.19 |
| Total Assets
| 810.91 | 1,372.649 | 1,225.862 | 494.466 | 472.407 | 442.723 | 487.352 | 430.421 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 23.038 | 37.549 | 16.915 | 4.422 | 6.44 | 8.207 | 8.368 | 5.383 |
| Short Term Debt
| 31.905 | 33.056 | 18.038 | 15 | 10 | 5.25 | 37.684 | 7.876 |
| Tax Payables
| 4.749 | 2.572 | 8.139 | 2.434 | 2.555 | 2.032 | 2.656 | 1.313 |
| Deferred Revenue
| 4.749 | 0 | 142.348 | 99.241 | 56.956 | 40.132 | 34.368 | 25.969 |
| Other Current Liabilities
| 115.805 | 233.412 | 3.558 | 3.926 | 15.619 | 11.839 | 7.27 | 12.928 |
| Total Current Liabilities
| 175.497 | 304.017 | 180.859 | 122.589 | 89.015 | 65.428 | 87.69 | 52.156 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 366.998 | 385.01 | 339.644 | 173.378 | 187.965 | 189.578 | 150.829 | 163.1 |
| Deferred Revenue Non-Current
| 10.573 | 0 | 0 | 29.249 | 25.255 | 33.063 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 1.213 | 154.001 | 133.518 | 3.362 | 3.874 | 3.955 | 8.78 | 9.328 |
| Other Non-Current Liabilities
| 35.511 | 189.289 | 38.052 | 21.728 | 20.681 | 5.432 | 47.715 | 28.348 |
| Total Non-Current Liabilities
| 414.295 | 728.3 | 511.214 | 227.717 | 237.775 | 232.028 | 207.324 | 200.776 |
| Total Liabilities
| 589.792 | 1,032.317 | 692.073 | 350.306 | 326.79 | 297.456 | 295.014 | 252.932 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 168 | 168 | 168 | 118 |
| Common Stock
| 0.079 | 0.078 | 0.075 | 285.173 | 285.147 | 285.153 | 113.373 | 113.4 |
| Retained Earnings
| -321.536 | -165.306 | -6.602 | -144.539 | -141.7 | -139.821 | -91.84 | -56.495 |
| Accumulated Other Comprehensive Income/Loss
| 0.794 | -0.11 | 0.179 | 1.607 | -0.465 | -0.065 | -0.65 | 0.014 |
| Other Total Stockholders Equity
| 494.254 | 481.919 | 465.272 | 0 | -168 | -168 | 3.455 | 2.57 |
| Total Shareholders Equity
| 173.591 | 316.581 | 458.924 | 142.241 | 142.982 | 145.267 | 192.338 | 177.489 |
| Total Equity
| 221.118 | 340.332 | 533.789 | 144.16 | 145.617 | 145.267 | 192.338 | 177.489 |
| Total Liabilities & Shareholders Equity
| 810.91 | 1,372.649 | 1,225.862 | 494.466 | 472.407 | 442.723 | 487.352 | 430.421 |